Clinical Trial Update: Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma (PRECAM) [Phase 2]

View source ↗

Summary

Phase 2 PRECAM trial evaluating preoperative short-course radiation followed by Envafolimab plus CAPEOX in microsatellite-stable locally advanced rectal adenoca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Envafolimab (envafolimab)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sir Run Run Shaw Hospital | Conditions: MSS Locally Advanced Rectal Adenocarcinoma | Phase 2 | Status: COMPLETED